Getting to goal in complex patients

Clinical Cardiology

Volumn 26, Issue 2 SUPPL., 2003, Pages

  Ram, C Venkata S ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Texas Blood Pressure Institute   (United States)

Author keywords

Calcium antagonists; Combination therapy; Complex hypertension; Goal blood pressure; Treat to goal target; Uncontrolled hypertension

Indexed keywords

AGED; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY FAILURE; COMPLEX HYPERTENSION; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; HIGH RISK POPULATION; HUMAN; HYPERTENSION; MEDICAL DECISION MAKING; NEGRO; VASCULAR DISEASE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DECISION MAKING; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DRUG THERAPY, COMBINATION; HUMANS; HYPERTENSION; HYPERTENSION, RENAL;

EID: 0037316234     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (28)

1. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S: Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998;351:1755-1762
2. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Br Med J 1998;317:703-713
3. Zhang ZH, Francis J, Weiss RM, Felder RB, The renin-angiotensin-aldosterone system excites hypothalamic paraventricular nucleus neurons in heart failure. Am J Physiol Heart Circ Physiol 2002;283:H423-H433
4. Kurpesa M, Trzos E, Drozdz J, Bednarkiewicz Z, KrzeminskaPakula M: Myocardial ischemia and autonomic activity in dippers and non-dippers with coronary artery disease: Assessment of normotensive and hypertensive patients. Int J Cardiol 2002;83: 133-142
5. Pepine CJ: Potential role of angiotensin-converting enzyme inhibition in myocardial ischemia and current clinical trials (abstr). Clin Cardiol 1997;20 (suppl II):II-58-II-64
6. Wenzel RR, Bruck H, Noll G, Schafers RF, Daul AE, Philipp T: Antihypertensive drugs and the sympathetic nervous system (abstr). J Cardiovasc Pharmacol 2000;35:S43-S52
7. Ram CV: Antihypertensive drugs: An overview. Am J Cardiovasc Drugs 2002;2:77-89
8. Gradman AH, Cutler NR, Davis PJ, Robbins JA, Weiss RJ, Wood BC, Michelson EL: Long-term efficacy, tolerability, and safety of the combination of enalapril and felodipine ER in the treatment of hypertension. Enalapril-Felodipine ER Factorial Study Group. Clin Ther 1998;20:527-538
9. Scholze J, Zilles P, Compagnone D: Verapamil SR and trandolapril combination therapy in hypertension - a clinical trial of factorial design. German Hypertension Study Group. Br J Clin Pharmacol 1998;45:491-495
10. Karlberg BE, Lins LE, Hermansson K: Efficacy and safety of telmisartan, a selective ATI receptor antagonist, compared with enalapril in elderly patients with primary hypertension. TEES Study Group. J Hypertens 1999;17:293-302
11. Fenves A, Ram CV: Are angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers becoming the treatment of choice in African-Americans? (abstr). Curr Hypertens Rep 2002;4: 286-289
12. Sareli P, Radevski IV, Valtchanova ZP, Libhaber E, Candy GP, Hond ED, Libhaber C, Skudicky D, Wang JG, Staessen JA: Efficacy of different drug classes used to initiate antihypertensive treatment in black subjects: Results of a randomized trial in Johannesburg, South Africa. Arch Intern Med 2001;161:965-971
13. Skoularigis J, Eitzman L, Davis J, Strugo V, Sareli P: Nifedipine versus captopril in the management of moderate hypertension in black patients. Am J Hypertens 1994;7:440-447
14. Materson BJ. Reda DJ, Cushman WC, Massie BM, Freis ED. Kochar MS, Hamburger RJ, Fye C, Lakshman R, Gottdiener J. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med 1993;328:914-921
15. Materson BJ, Reda DJ, Cushman WC: Department of Veterans Affairs single-drug therapy of hypertension study. Revised figures and new data. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Am J Hypertens 1995;8: 189-192
16. Franklin SS, Larson MG, Khan SA, Wong ND, Leip EP, Kannel WB, Levy D: Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation 2001;103:1245-1249
17. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (also available at: www.ama-assn.org/intemal). Arch Intern Med 1997; 157:2413-2446
18. Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, Toto R, Tuttle K, Douglas J, Hsueh W, Sowers J: Preserving renal function in adults with hypertension and diabetes: A consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 2000;36:646-661
19. Chaturvedi N, Sjolie AK, Stephenson JM, Abrahamian H, Keipes M, Castellarin A. Rogulja-Pepeonik Z, Fuller JH: Effect of lisinopril on progression of retinopathy in normotensive people with type I diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus. Lancet 1998;351:28-31
20. Reja A, Tesfaye S, Harris ND, Ward JD: Is ACE inhibition with lisinopril helpful in diabetic neuropathy? (abstr). Diabet Med 1995; 12:307-309
21. Velussi M, Brocco E, Frigato F. Zolli M, Muollo B, Maioli M, Carraro A, Tonolo G, Fresu P, Cemigoi AM, Fioretto P, Nosadini R: Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients. Diabetes 1996;45:216-222
22. Shigihara T, Sato A, Hayashi K, Saruta T: Effect of combination therapy of angiotensin-converting enzyme inhibitor plus calcium-channel blocker on urinary albumin excretion in hypertensive microalbuminuric patients with type II diabetes. Hypertens Res 2000;23:219-226
23. Herlitz H, Harris K, Risler T, Boner G, Bemheim J, Chanard J, Aurell M: The effects of an ACE inhibitor and a calcium antagonist on the progression of renal disease: The Nephros Study. Nephrol Dial Transplant 2001;16:2158-2165
24. Wright JT Jr, Kusek JW, Toto RD, Lee JY, Agodoa LY. Kirk KA, Randall OS, Glassock R: Design and baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Control Clin Trials 1996;17: 3S-16S
25. Agodoa LY, Appel L, Bakris GL, Beck G, Bourgoignie J, Briggs JP, Charleston J, Cheek D, Cleveland W, Douglas JG, Douglas M, Dowie D, Faulkner M, Gabriel A, Gassman J, Greene T, Hall Y, Hebert L, Hiremath L, Jamerson K, Johnson CJ, Kopple J. Kusek J, Lash J, Lea J, Lewis JB, Lipkowitz M, Massry S, Middleton J, Miller ER III, Norris K, O'Connor D, Ojo A, Phillips RA, Pogue V, Rahman M, Randall OS, Rostand S, Schulman G, Smith W, Thomley- Brown D, Tisher CC, Toto RD, Wright JT Jr, Xu S: Effect of ramipril vs. amlodipine on renal outcomes in hypertensive nephrosclerosis: A randomized controlled trial. J Am Med Assoc 2001;285:2719-2728
26. Schrier RW, Estacio RO, Esler A, Mehler P: Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney Int 2002;61:1086-1097
27. Estacio RO, Jeffers BW, Hiatt WR, Biggerstaff SL, Gifford N, Schrier RW: The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. NEnglJMed 1998;338:645-652
28. Franklin SS, Jacobs MJ, Wong ND, L'Italien GJ, Lapuerta P: Predominance of isolated systolic hypertension among middle- aged and elderly US hypertensives: Analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension 2001;37:869-874